Answers are grounded in this paper and cite their sources.
Background: Parathyroid carcinoma is a rare endocrine malignancy accounting for less than 1% of primary hyperparathyroidism. Severe hypercalcemia and extensive skeletal involvement may occasionally produce brown tumors that mimic metastatic bone disease on imaging. Case Presentation: A 28-year-old woman presented with progressive anterior neck swelling and severe left hip pain following minor trauma, with progressive limitation of mobility. Imaging demonstrated a pathological femoral fracture and multiple expansile skeletal lesions. Neck ultrasonography identified a heterogeneous lesion inferior to the right thyroid lobe. Biochemical evaluation showed marked hypercalcemia (15.19 mg/dL), markedly elevated parathyroid hormone (944 pg/mL), and elevated alkaline phosphatase (479 U/L), with a serum phosphate level of 3.48 mg/dL. Whole-body FDG PET/CT demonstrated multiple skeletal lesions that initially raised concern for metastatic disease. Surgical exploration revealed a firm, enlarged right inferior parathyroid mass with adherence to surrounding soft tissues. En bloc excision was performed with preservation of the recurrent laryngeal nerve. Histopathology demonstrated capsular invasion and features consistent with parathyroid carcinoma. Postoperatively, serum calcium and PTH decreased substantially, with improvement in bone pain and mobility. Conclusion: Parathyroid carcinoma should be considered in patients with severe hypercalcemia, very high PTH concentrations, a cervical mass, and multifocal osteolytic skeletal lesions. Brown tumors can closely mimic metastatic disease; correlation of biochemical, radiological, operative, and histopathological findings is essential to avoid diagnostic error and inappropriate oncological treatment.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: